Search Results - "Vtoraya, O."

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the aromatase inhibitors letrozole and anastrozole

    An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the aromatase inhibitors letrozole and anastrozole by Rose, C., Vtoraya, O., Pluzanska, A., Davidson, N., Gershanovich, M., Thomas, R., Johnson, S., Caicedo, J.J., Gervasio, H., Manikhas, G., Ben Ayed, F., Burdette-Radoux, S., Chaudri-Ross, H.A., Lang, R.

    Published in European journal of cancer (1990) (01-11-2003)
    “…It was previously shown that letrozole (Femara®) was significantly more potent than anastrozole (Arimidex®) in inhibiting aromatase activity in vitro and in…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    6543 POSTER Radiotherapy Prolongs Survival in Locally Advanced, Inoperable Gastric Cancer

    6543 POSTER Radiotherapy Prolongs Survival in Locally Advanced, Inoperable Gastric Cancer by Valkov, M, Asakhin, S, Levit, M, Vtoraya, O, Ruzhnikova, A, Litinskiy, S

    Published in European journal of cancer (1990) (2011)
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Phase Ib study of the anti-neovascular agent MBT-0206 to evaluate safety and efficacy in patients with metastatic breast cancer

    Phase Ib study of the anti-neovascular agent MBT-0206 to evaluate safety and efficacy in patients with metastatic breast cancer by Bartelheim, K., Ognerubov, N. A., Semiglazov, V. F., Vtoraya, O. M., Kaletta, C., Reichenberger, I., Michaelis, U., Naujoks, K., Clemens, M.

    Published in Journal of clinical oncology (15-07-2004)
    “…Abstract only…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Phase Ib study of the anti-neovascular agent MBT-0206 to evaluate safety and efficacy in patients with metastatic breast cancer

    Phase Ib study of the anti-neovascular agent MBT-0206 to evaluate safety and efficacy in patients with metastatic breast cancer by Bartelheim, K., Ognerubov, N. A., Semiglazov, V. F., Vtoraya, O. M., Kaletta, C., Reichenberger, I., Michaelis, U., Naujoks, K., Clemens, M.

    Published in Journal of clinical oncology (15-07-2004)
    “…Abstract only…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    An open randomised trial of second-line endocrine therapy in advanced breast cancer

    An open randomised trial of second-line endocrine therapy in advanced breast cancer by Rose, C., Vtoraya, O., Pluzanska, A., Davidson, N., Gershanovich, M., Thomas, R., Johnson, S., Caicedo, J.J., Gervasio, H., Manikhas, G., Ben Ayed, F., Burdette-Radoux, S., Chaudri-Ross, H.A., Lang, R.

    Published in European journal of cancer (1990) (01-11-2003)
    Get full text
    Journal Article
    Save to List
    Saved in:
  6. 6
    Otkrytoe nesravnitel'noe issledovanie gikamtina v kachestve terapii II linii pri rake yaichnikov. Lechenie retsidivov raka yaichnikov gikamtinom - opyt rossiyskikh regionov (predvaritel'naya otsenka neposredstvennykh rezul'tatov)

    Otkrytoe nesravnitel'noe issledovanie gikamtina v kachestve terapii II linii pri rake yaichnikov. Lechenie retsidivov raka yaichnikov gikamtinom - opyt rossiyskikh regionov (predvaritel'naya otsenka neposredstvennykh rezul'tatov) by I V Poddubnaya, R Sh Khasanov, V N Ruchkin, A N Lazarev, M Yu Byakhov, O M Vtoraya, V S Yurchenko

    “…Появление новых противоопухолевых препаратов сказалось на положительных результатах лечения рака яичников. Вторая линия терапии - всегда более сложная…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: